Janux Therapeutics

Janux Therapeutics(JANX)

SAN DIEGO, CA
Biotechnology

Focus: Immunotherapies for Cancer

Janux Therapeutics is a life sciences company focused on Immunotherapies for Cancer.

Oncology
Funding Stage
PUBLIC
Open Jobs
13

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT05519449Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Phase 1
JANX011
Autoimmune
Phase 1
Clinical Trials (1)
NCT07291323Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.
Phase 1
Clinical Trials (1)
NCT05783622Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Phase 1

Open Jobs (13)

Interview Prep Quick Facts
Portfolio: 3 clinical trials
Top TAs: Oncology, Immunology
SEC Filings: 2 available
Open Roles: 13 active jobs
Therapeutic Area Focus
Oncology
2 pipeline
Immunology
1 pipeline
Marketed
Pipeline

Financials (FY2025)

Revenue
$8M6%
R&D Spend
$55M(679%)3%
Net Income
-$58M
Cash
$431M

Hiring Trend

Stable
13
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles